Landmark clinical trial for management of severe hearing loss launches
The world’s first study to establish the best treatment options for adults struggling with severe hearing loss has launched at UCLH.
BRC News
£100,000 for UCLH team to help deliver net zero NHS
A collaboration between UCLH, UCL and industry to cut use of anaesthetic gases has been awarded £99,703 by SBRI Healthcare – an NHS funded programme to support an historic drive to deliver a net zero NHS.
Covid-19 vaccine booster provides good antibody protection against Omicron
A third ‘booster’ dose of COVID-19 vaccine successfully raises antibody levels that neutralise the Omicron variant.
Covid-19 vaccines can be given to people with rheumatic and musculoskeletal diseases
It is safe and effective to vaccinate people with inflammatory or autoimmune rheumatic and musculoskeletal diseases such as arthritis and lupus, a study led by UCL has found.
New approach to make research a part of everyday clinical care
UCLH clinicians and researchers are to test a novel way of running clinical trials using the hospital’s electronic health records system.
Second generation CAR T-cell therapy trialled in patients
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
Abiraterone could halve risk of prostate cancer death for some patients
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death.
Potential drug targets identified for treating Parkinson’s
UCL researchers have identified up to 23 genes which could be targeted by drugs to treat Parkinson’s disease.
Portable air purifiers could cut Covid-19 transmission in hospital
Cheap portable air filters could cut Covid-19 transmission in hospitals and be a simple way to reduce hospital waiting times as a result of the pandemic, according to UCL and UCLH research.
People with Long COVID after hospitalisation face limited recovery after one year
People who were hospitalised with COVID-19 and continued to experience symptoms at five months show limited further recovery one year after hospital discharge, according to the latest results of the PHOSP (Post-Hospitalisation) COVID study.
Framework for quantifying equity in research access developed
A framework for quantifying the equity of access to healthcare research has been developed at UCLH and UCL.
Study at UCLH publishes COVID-19 booster data
Six COVID-19 vaccines are safe and boost immunity for people who have had two doses of AstraZeneca or Pfizer-BioNTech, results from the UK-wide COV-BOOST trial show.
Wearable technology improves quality of life for people with balance disorders
Innovative technology to help older people with balance disorders can significantly improve patients’ balance, their ability to perform everyday tasks and their social wellbeing.
Prestigious medical physics prize for UCL academic
UCL academic Professor Brian Hutton has been awarded the prestigious Peter Mansfield Medal and Prize by the Institute of Physics (IOP) for his distinguished contributions to the field of medical physics.
